Related Experiment Video
Updated: May 2, 2026
Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Aspartame, as an artificial sweetener, does not affect renal function and antioxidative states in mice
Kenta Torigoe1, Miki Torigoe2, Satoru Oka2
1Department of Nephrology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852- 8501, Japan. ktorigoe@nagasaki-u.ac.jp.
Background And Objective:
Aspartame (L-aspartyl L-phenylalanine methyl ester) is an artificial sweetener widely used as a sugar substitute. There are concerns regarding the effects of high aspartame doses on the kidney owing to oxidative stress; however, whether the maximum allowed dose of aspartame in humans affects the kidneys remains unknown. Therefore, in this study, we investigated whether the maximum allowed dose of aspartame in humans affects the kidneys.
Methods:
In this study, animals were fed a folate-deficient diet to mimic human aspartame metabolism. Eight-week-old ICR mice were divided into control (CTL), 40 mg/kg/day of aspartame-administered (ASP), folate-deficient diet (FD), and 40 mg/kg/day of aspartame-administered with a folate-deficient diet (FD + ASP) groups. Aspartame was administered orally for eight weeks. Thereafter, we evaluated aspartame's effect on kidneys via histological analysis.
Results:
There were no differences in serum creatinine and blood urea nitrogen levels between the CTL and ASP groups or between the FD and FD + ASP groups. There was no histological change in the kidneys in any group. The expression of superoxide dismutase and 4-hydroxy-2-nonenal in the kidney did not differ between the CTL and ASP groups or the FD and FD + ASP groups.
Conclusion:
Our findings indicate that the allowed doses of aspartame in humans may not affect kidney function or oxidative states.
